The purpose of this study is to evaluate whether the addition of warfarin (a blood-thinning
medication) to an antiplatelet therapy like aspirin is better than antiplatelet therapy alone
(i.e. usual treatment) for the prevention of leg surgery, heart attacks, stroke and death in
people with peripheral vascular disease.
Phase:
Phase 3
Details
Lead Sponsor:
Anand, Sonia, M.D.
Collaborators:
Canadian Institutes of Health Research (CIHR) Heart and Stroke Foundation of Ontario